Kirill Golovanov
IT IS clearly very odd that a company that has long traded in the natural resources sector has, overnight, turned itself into a pharmaceutical operation. This exact transformation took place on Friday July 27 at an EGM, without even a whimper from the Irish Stock Exchange head honchos. Instead, essentially, of exploring for gold in... Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!
